Donald Trump’s tariff move impacts Indian pharma stocks. Companies like Sun Pharma, Cipla, and Dr. Reddy’s face potential declines. US represents a major market for Indian exports.
Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in
You May Also Like
Posted in
All
Payment lags can help curb digital fraud: RBI
Posted by
avianscape.enterprises@gmail.com
More From Author
Posted in
All
Payment lags can help curb digital fraud: RBI
Posted by
avianscape.enterprises@gmail.com